tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Neumora Therapeutics, Inc. (NMRA) Stock News & Sentiment

Compare
288 Followers
Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study
Premium
Ratings
Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study
6d ago
NMRA
Douglas Tsao Recommends ‘Buy’ for Neumora Therapeutics Due to Navacaprant’s Market Potential and Differentiated Pharmacology
Premium
Ratings
Douglas Tsao Recommends ‘Buy’ for Neumora Therapeutics Due to Navacaprant’s Market Potential and Differentiated Pharmacology
1M ago
NMRA
Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks
Premium
Ratings
Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks
1M ago
NMRA
Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays
Premium
Ratings
Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays
1M ago
NMRA
Neumora Therapeutics Reports 2024 Financial Results and Updates
Premium
Company Announcements
Neumora Therapeutics Reports 2024 Financial Results and Updates
1M ago
NMRA
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
1M ago
NMRA
Strategic Adjustments and Future Prospects Drive Buy Rating for Neumora Therapeutics
Premium
Ratings
Strategic Adjustments and Future Prospects Drive Buy Rating for Neumora Therapeutics
1M ago
NMRA
More NMRA News >

NMRA News on the Web

William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold
TipRanks News
Neutral
JNJ Halts Development of Depression Drug Over Efficacy Concerns
Yahoo Finance
Neutral
J&J drops Phase III MDD programme due to lack of efficacy
Clinical Trials Arena
Neutral
J&J scraps depression testing for potential blockbuster drug
BioPharma Dive
Neutral
RBC Capital Sticks to Its Hold Rating for Neumora Therapeutics, Inc. (NMRA)
TipRanks News
Neutral
Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data
BioPharma Dive
Neutral
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
TipRanks News
Neutral
Neumora Therapeutics, Inc. (NMRA) Gets a Buy from Mizuho Securities
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
NMRA
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NMRA’s Media Buzz Sentiment?
Currently, no data Available
What is NMRA’s weekly average amount of articles?
Currently, no data Available
What is NMRA’s News Sentiment?
59% of articles about NMRA were positive this week, compared to its sector average of 62%.
    Healthcare Stocks that are Trending in the News
    RYTMRhythm Pharmaceuticals
    SLPSimulations Plus
    UNHUnitedHealth
    BRKRBruker
    RGTLFArgent Biopharma
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing